Stocks and Investing Stocks and Investing
Tue, July 11, 2023

Michael Leithead Maintained (CC) at Hold with Increased Target to $40 on, Jul 11th, 2023


Published on 2024-10-28 04:43:26 - WOPRAI, Michael Leithead
  Print publication without navigation


Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $38 to $40 on, Jul 11th, 2023.

Michael has made no other calls on CC in the last 4 months.



There are 6 other peers that have a rating on CC. Out of the 6 peers that are also analyzing CC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $37 on, Thursday, June 22nd, 2023
  • Arun Viswanathan of "RBC Capital" Maintained at Hold with Increased Target to $37 on, Friday, June 9th, 2023
  • Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 31st, 2023


These are the ratings of the 3 analyists that currently disagree with Michael


  • Joshua Spector of "UBS" Maintained at Strong Buy with Increased Target to $43 on, Tuesday, June 13th, 2023
  • John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $64 on, Monday, June 5th, 2023
  • John Roberts of "Credit Suisse" Maintained at Sell with Decreased Target to $25 on, Friday, April 28th, 2023
Contributing Sources